Sjögren’s syndrome
Julius Birnbaum, MD
1 University of Pittsburgh Medical Center
Wexford, PA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Brent Goodman, MD
Mayo Clinic
Scottsdale, AZ, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Arun Varadhachary, MD, PhD
Washington University in St. Louis
St. Louis, MO, United States
Disclosure(s): Biogen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Capricor: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Edgewise: Grant/Research Support (Ongoing); Epirium: Advisor or Review Panel Member (Terminated), Grant/Research Support (Terminated); Genentech: Grant/Research Support (Ongoing); NML: Grant/Research Support (Ongoing)
Nervous system manifestations of Sjogren’s syndrome manifest in multiple forms, resulting in marked heterogeneity of clinical presentation and a complex algorithm for diagnostic evaluation. Management recommendations lack strong empiric evidence. Postural tachycardia syndrome and other forms of dysautonomia are increasingly associated with Sjogren’s Syndrome and can be challenging to diagnose and manage. Novel insights into the connection between immunity and migraines is opening horizons to deeper understanding of certain neurologic manifestations of Sjogren’s Syndrome.
Speaker: Brent Goodman, MD – Mayo Clinic
Speaker: Arun Varadhachary, MD, PhD – Washington University in St. Louis
Speaker: Julius Birnbaum, MD – 1 University of Pittsburgh Medical Center